Skip to main content
Fig. 10 | Clinical Epigenetics

Fig. 10

From: Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

Fig. 10

Kaplan-Meier analysis: Association between combined 5hmC/5caC score and time to BCR after RP in ERG− PC. To evaluate the prognostic potential of combined 5hmC/5caC IHC score in ERG− PCs, three patient subgroups were defined as low (5hmC ≤ 1 and 5caC ≤ 1; blue curve), moderate (5hmC ≤ 1 and 5caC > 1, or 5hmC > 1 and 5caC ≤ 1; green curve), and high (5hmC > 1 and 5caC > 1; red curve). The number of patients in each subgroup and p values for 2-sided log-rank tests are listed at the bottom. Significant p values are marked by an asterisk (*)

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us